About Us
The National Center for Fatality Review and Prevention is the national resource and data center for Fetal and Infant Mortality Review and Child Death Review.
The Center has four major objectives:
- Provide leadership, training and technical support to the CDR and FIMR programs.
- Manage a National Case Reporting System that will promote high quality FIMR and CDR data collection, analysis and dissemination to local, state and national audiences.
- Promote coordination among review processes.
- Build partnerships at the state and local level to move CDR and FIMR review findings into recommendations and actions that will improve agency systems and prevent deaths and serious injuries.
Review Programs
There are more than 1,350 Child Death Review Teams in all 50 states, the District of Columbia, Guam and the Navajo Nation. There are 173 Fetal and Infant Mortality Review Teams in 29 states. There are also programs in other countries.
Our 2016 Status Reports are available for both FIMR and CDR.
Find information on these CDR and FIMR teams
News/Events
Webinar: Using Social Determinants of Health to Inform Fatality Review
Free webinar hosted by the National Center for Fatality Review and Prevention
When: June 7, 2017
CDR Process
Find information, tools and resources to build, maintain and evaluate an effective CDR team or program.
Learn More
FIMR Process
Find information, tools and resources to build, maintain and evaluate an effective FIMR team or program.
Data
Search for mortality data and learn more about the National Fatality Review Case Reporting System.
Causes
Search for information by specific cause of deaths and learn about effective prevention strategies.
This website was made possible in part by Cooperative Agreement Number UG7MC28482 from the US Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB). Its contents are solely the responsibility of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.